MicroRNAs: toward the clinic for breast cancer patients.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Seminars in Oncology

• Publication date

  2011-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/j.seminoncol.2011.08.005PMID 22082762
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of ferritin alterations in human breast cancer cells

  2011cited by this paper
• miR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1

  2011cited by this paper
• MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer

  2011cited by this paper
• Let-7 family miRNAs regulate estrogen receptor alpha signaling in estrogen receptor positive breast cancer

  2011cited by this paper
• Micro‐RNAs and breast cancer

  2010cited by this paper
• MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer.

  2010cited by this paper
• miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-α in human breast cancer cells

  2010cited by this paper
• The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis

  2010cited by this paper
• Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease.

  2010cited by this paper
• Single nucleotide polymorphisms in miRNA binding sites and miRNA genes as breast/ovarian cancer risk modifiers in Jewish high‐risk women

  2010cited by this paper
• The association between two polymorphisms of eNOS and breast cancer risk: a meta-analysis.

  2010cited by this paper
• miR‐20b modulates VEGF expression by targeting HIF‐1α and STAT3 in MCF‐7 breast cancer cells

  2010cited by this paper
• miR-10b Targets Tiam1

  2010cited by this paper
• Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer

  2010cited by this paper
• Regulation of the Expression and Activity of the Antiangiogenic Homeobox Gene GAX/MEOX2 by ZEB2 and MicroRNA-221

  2010cited by this paper
• Overexpression of miR-21 Promotes an In vitro Metastatic Phenotype by Targeting the Tumor Suppressor RHOB

  2010cited by this paper
• Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway.

  2010cited by this paper
• MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene.

  2010cited by this paper
• The role of microRNA-128a in regulating TGFbeta signaling in letrozole-resistant breast cancer cells

  2010cited by this paper
• Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model

  2010cited by this paper
• microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling

  2010cited by this paper
• An estrogen receptor α suppressor, microRNA‐22, is downregulated in estrogen receptor α‐positive human breast cancer cell lines and clinical samples

  2010cited by this paper
• MicroRNA-27a Indirectly Regulates Estrogen Receptor {alpha} Expression and Hormone Responsiveness in MCF-7 Breast Cancer Cells.

  2010cited by this paper
• Downregulation of microRNA miR-520h by E1A contributes to anticancer activity.

  2010cited by this paper
• Abstract 2350: MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1

  2010cited by this paper
• Estrogen receptor {beta}1 expression is regulated by miR-92 in breast cancer.

  2010cited by this paper
• miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis

  2010cited by this paper
• Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1.

  2010cited by this paper
• Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells

  2010cited by this paper
• MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers

  2010cited by this paper
• E‐cadherin transcriptional down‐regulation by epigenetic and microRNA‐200 family alterations is related to mesenchymal and drug‐resistant phenotypes in human breast cancer cells

  2010cited by this paper
• MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression

  2010cited by this paper
• A MicroRNA targeting dicer for metastasis control.

  2010cited by this paper
• A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk

  2010cited by this paper
• Fluorescence-Based Codetection with Protein Markers Reveals Distinct Cellular Compartments for Altered MicroRNA Expression in Solid Tumors

  2010cited by this paper
• MicroRNA-155 Regulates Cell Survival, Growth, and Chemosensitivity by Targeting FOXO3a in Breast Cancer*

  2010cited by this paper
• miR-1226 targets expression of the mucin 1 oncoprotein and induces cell death.

  2010cited by this paper
• microRNA, cell cycle, and human breast cancer.

  2010cited by this paper
• MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression*

  2010cited by this paper
• MUCIN 1 ONCOPROTEIN EXPRESSION IS SUPPRESSED BY THE miR-125b ONCOMIR.

  2010cited by this paper
• miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers

  2010cited by this paper
• Alterations of microRNAs and their targets are associated with acquired resistance of MCF‐7 breast cancer cells to cisplatin

  2010cited by this paper
• miR-200bc/429 cluster targets PLCγ1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer

  2010cited by this paper
• Concurrent suppression of integrin alpha5, radixin, and RhoA phenocopies the effects of miR-31 on metastasis.

  2010cited by this paper
• Hyaluronan-CD44 Interaction with Protein Kinase Cϵ Promotes Oncogenic Signaling by the Stem Cell Marker Nanog and the Production of MicroRNA-21, Leading to Down-regulation of the Tumor Suppressor Protein PDCD4, Anti-apoptosis, and Chemotherapy Resistance in Breast Tumor Cells*

  2009cited by this paper
• miR-145 inhibits breast cancer cell growth through RTKN.

  2009cited by this paper
• A Short Hairpin DNA Analogous to miR-125b Inhibits C-Raf Expression, Proliferation, and Survival of Breast Cancer Cells

  2009cited by this paper
• microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis.

  2009cited by this paper
• Estradiol-regulated microRNAs control estradiol response in breast cancer cells

  2009cited by this paper
• MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.

  2009cited by this paper
• microRNA-205 regulates HER3 in human breast cancer.

  2009cited by this paper
• ST14 (Suppression of Tumorigenicity 14) Gene Is a Target for miR-27b, and the Inhibitory Effect of ST14 on Cell Growth Is Independent of miR-27b Regulation*

  2009cited by this paper
• MicroRNAs 373 and 520c are downregulated in prostate cancer, suppress CD44 translation and enhance invasion of prostate cancer cells in vitro.

  2009cited by this paper
• The role of miR-206 in the epidermal growth factor (EGF) induced repression of estrogen receptor-alpha (ERalpha) signaling and a luminal phenotype in MCF-7 breast cancer cells.

  2009cited by this paper
• MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents

  2009cited by this paper
• Clinical significance of miR-21 expression in breast cancer: SYBR-Green I-based real-time RT-PCR study of invasive ductal carcinoma.

  2009cited by this paper
• MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets

  2009cited by this paper
• Identification of miR‐21 targets in breast cancer cells using a quantitative proteomic approach

  2009cited by this paper
• Common genetic variants in pre‐microRNAs were associated with increased risk of breast cancer in Chinese women

  2009cited by this paper
• MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells.

  2009cited by this paper
• High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-β1

  2009cited by this paper
• Regulation of Epidermal Growth Factor Receptor Signaling in Human Cancer Cells by MicroRNA-7*

  2009cited by this paper
• Epithelial-mesenchymal transitions in development and disease.

  2009cited by this paper
• Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model.

  2009cited by this paper
• miR-22 Inhibits Estrogen Signaling by Directly Targeting the Estrogen Receptor α mRNA

  2009cited by this paper
• A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis.

  2009cited by this paper
• MicroRNA regulation of DNA repair gene expression in hypoxic stress.

  2009cited by this paper
• The estrogen receptor-α-induced microRNA signature regulates itself and its transcriptional response

  2009cited by this paper
• MicroRNA-125a represses cell growth by targeting HuR in breast cancer

  2009cited by this paper
• Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues

  2009cited by this paper
• An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation.

  2009cited by this paper
• miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer.

  2009cited by this paper
• MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT

  2009cited by this paper
• Germline mutation of microRNA-125a is associated with breast cancer

  2009cited by this paper
• Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma

  2009cited by this paper
• Widespread estrogen-dependent repression of micrornas involved in breast tumor cell growth.

  2009cited by this paper
• Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck

  2009cited by this paper
• Estradiol downregulates miR-21 expression and miR-21 gene targets in MCF-7 breast cancer cells.

  2009cited by this paper
• Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009

  2009cited by this paper
• Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells

  2009cited by this paper
• A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women.

  2009cited by this paper
• An miR-502–Binding Site Single-Nucleotide Polymorphism in the 3′-Untranslated Region of the SET8 Gene Is Associated with Early Age of Breast Cancer Onset

  2009cited by this paper
• Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.

  2009cited by this paper
• Novel genetic variants in microRNA genes and familial breast cancer

  2009cited by this paper
• miR-22 Inhibits Estrogen Signaling by Directly Targeting the Estrogen Receptor α mRNA

  2009cited by this paper
• miR‐29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis

  2009cited by this paper
• Human CYP24 Catalyzing the Inactivation of Calcitriol Is Post-Transcriptionally Regulated by miR-125b

  2009cited by this paper
• MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer

  2009cited by this paper
• MicroRNA-661, a c/EBPalpha target, inhibits metastatic tumor antigen 1 and regulates its functions.

  2009cited by this paper
• MicroRNA-mediated Regulation of Ubc9 Expression in Cancer Cells

  2009cited by this paper
• MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene

  2008cited by this paper
• A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis.

  2008cited by this paper
• A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation

  2008cited by this paper
• Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin

  2008cited by this paper
• Endogenous human microRNAs that suppress breast cancer metastasis

  2008cited by this paper
• MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis.

  2008cited by this paper
• Circulating microRNAs as stable blood-based markers for cancer detection

  2008cited by this paper
• Expression of microRNA-146 suppresses NF-κB activity with reduction of metastatic potential in breast cancer cells

  2008cited by this paper
• MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers

  2008cited by this paper
• MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions.

  2008cited by this paper

• The role of miR-1180-3p in breast cancer and its effect on the cell functions of breast cancer cells.

  2025cites this paper
• SNPs in miRNAs and Target Sequences: Role in Cancer and Diabetes

  2021cites this paper
• Role of miR-21 as an authentic oncogene in mediating drug resistance in breast cancer.

  2020cites this paper
• Unravelling the role of long non-coding RNA - LINC01087 in breast cancer

  2019cites this paper
• Breast Cancer and miR-SNPs: The Importance of miR Germ-Line Genetics

  2019cites this paper
• Evidences from a Systematic Review and Meta-Analysis Unveil the Role of MiRNA Polymorphisms in the Predisposition to Female Neoplasms

  2019cites this paper
• Down‐regulation of microRNA‐19b in hormone receptor‐positive/HER2‐negative breast cancer

  2018cites this paper
• Upregulation of CXC chemokine receptor 4-CXC chemokine ligand 12 axis ininvasive breast carcinoma: A potent biomarker predicting lymph node metastasis

  2018cites this paper
• MicroRNA and mRNA Transcriptome Profiling in Primary Human Astrocytes Infected with Borrelia burgdorferi

  2017cites this paper
• MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer

  2016cites this paper
• MicroRNA analysis of breast ductal fluid in breast cancer patients

  2016cites this paper
• Aberrant expression of miR-9 in benign and malignant breast tumors.

  2016cites this paper
• Expression der Progesteronrezeptor-Membrankomponente 1 im Mammakarzinom vor und nach neoadjuvanter Therapie und anhand dessen Entwicklung eines immunreaktiven Scores

  2016cites this paper
• MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients

  2015cites this paper
• MicroRNAs Discriminate Familial from Sporadic Non-BRCA1/2 Breast Carcinoma Arising in Patients ≤35 Years

  2014cites this paper
• Targeting HER3 with miR-450b-3p suppresses breast cancer cells proliferation

  2014cites this paper
• Up-regulation of microRNA-10b is associated with the development of breast cancer brain metastasis.

  2014cites this paper
• The fusion of two worlds: Non-coding RNAs and extracellular vesicles - diagnostic and therapeutic implications (Review)

  2014cites this paper
• Molecular Pathogenesis of Breast Cancer and the Role of MicroRNAs

  2014cites this paper
• Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors.

  2014cites this paper
• MicroRNA expression profiles in human breast cancer cells after multifraction and single-dose radiation treatment.

  2014cites this paper
• MicroRNA-21 gene and cancer

  2013cites this paper
• Comprehensive microRNA Profiling of Prostate Cancer

  2013cites this paper
• High expression of miR-210 predicts poor survival in patients with breast cancer: a meta-analysis.

  2012cites this paper
• Epigenetics as a Therapeutic Target in Breast Cancer

  2012cites this paper
• Epigenetic Mechanisms in Commonly Occurring Cancers

  2012influential citation
• Eukaryotic signature proteins : guides to pathogenic eukaryotic parasites : a thesis presented in partial fulfilment of the requirements of the degree of PhD in Genetics at Massey University, Palmerston North, New Zealand

  2012cites this paper
• E16. Clinical implications of microRNAs in breast cancer

  2012influential citation
• MicroRNAs involved in regulating epithelial–mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics

  2012cites this paper
• Estrogen and retinoic acid antagonistically regulate several microRNA genes to control aerobic glycolysis in breast cancer cells.

  2012cites this paper
• Perspectives of Long Non-Coding RNAs in Cancer Diagnostics

  2012cites this paper